Sanofi Pasteur, A Sanofi Company

This study tests an mRNA vaccine designed to treat mild acne. About 120 adults aged 18 to 45 with mild facial acne will receive two doses of the vaccine or a placebo. Researchers will check safety, how the body responds, and whether acne lesions improve.

This study is testing an experimental mRNA vaccine to treat moderate to severe acne in adults aged 18 to 45. The vaccine aims to teach the immune system to fight acne-causing bacteria, potentially reducing pimples and lesions. Researchers will give up to three shots at different …

This study is a safety registry that tracks pregnant women in the US who received the MenQuadfi vaccine during pregnancy or within 30 days before their last period. Researchers will monitor the health of the mothers and their babies for any side effects or complications. The goal…

This study tracks the safety of the Dengvaxia vaccine in pregnant women who received it during pregnancy. Researchers will monitor mothers and their babies for any health issues after vaccination. The goal is to gather information, not to treat or cure disease.